Postdoctoral Researcher

The GIMM – Gulbenkian Institute for Molecular Medicine is a pioneering Portuguese private research foundation with an ambitious vision for fundamental scientific exploration and its profound impact on global health and well-being. Founded in 2023, GIMM is the result of the merge of two leading research institutes: Instituto de Medicina Molecular João Lobo Antunes (iMM) and Instituto Gulbenkian de Ciência (IGC) and dedicates to unraveling the fundamental mysteries of life and aims to be at the forefront of transdisciplinary research.

GIMM opens a call to hire a Postdoctoral Researcher correspondent to the initial level according to the Applicable Regulation, under an Unfixed-term contract under the project “ Production of donor regulatory T lymphocytes specific to antigens of the patient for the treatment of chronic graft versus host disease after hematopoietic stem cell transplantation ” with the funding support from FCT through national funds, co‑funded by the Lisbon Regional Programme 2030 (FEDER Funds) (#LISBOA2030-FEDER-00678800), operation 15692.

Regulation

• Decree-Law nr 57/2016, from 29th August, altered by Law nr 57/2017, from 19th July, that approves a Doctoral Hiring regime to stimulate Scientific and Technological Employment in all knowledge areas (RJEC).
• Portuguese Labor Law, approved by Law nr 7/2009, from 12th February in its current writing.
• Regulatory Decree Nr 11-A / 2017, of 29th December.
• Decree-Law nr 108/2023, of 22nd November.
• Optimization methodologies for purification and expansion of regulatory T cells.
• Establishment of protocols for the generation and expansion of recipient‑specific Treg in an HLA‑matched setting.
• Reproduce in vitro the immunologic milieu of human allo‑HSCT
• Perform a thorough characterization of the functional mechanisms of recipient‑specific Treg
• Evaluation of regulatory T cell (Treg) phenotype and functional ability following HSCT

Members of the Jury

According to article 28 nr 5 from REC and article 13 from Decree‑Law nr 57/2016, from 28th of August, altered by Law nr 57/2017, from 19th of July,the jury is composed by Professors João Forjaz de Lacerda (President of the Jury and Responsible for the Project), Diogo Silva and Marc Veldhoen (all PhD’s).

Start Date and workplace

The contract is expected to start in June 2026 and will remain only for the necessary execution period of the work plan; the activities will be developed in GIMM installations in Lisboa/ Oeiras and/or other necessary locations to their execution.

Monthly remuneration

Gross monthly Remuneration is 2408,11€, in accordance with subsection a), section 1, article 15 from Law nr 57/2017, 19th July, and with the remuneration position at initial level predicted in article 2 of Regulatory Decree nr 11-A/2017, of 29th December, correspondent to level 33 at Tabela Remuneratória Única, approved by Order nr 1553-C/2008, 31st December and updated by Decree‑Law nr 108/2023, of 22nd November.

Profile of Candidate

• a) PhD in immunology or related areas.
• b) Mandatory experience in cell culture techniques, flow cytometry, cell sorting (MACS and FACS), and handling of regulatory T cells from primary sources, particularly within the contexts described in the project’s activities.
• c) Ability to independently develop projects in the field of immunology/hematology.

Application process

The call is open from 2nd April until 15th May 2026 (30 working days), and the application documents (indicated below) should be submitted, in PDF format, to People & Culture Team through the email positions@gimm.pt , by identifying the reference of the position in the “Subject”.

• Detailed CV;
• PhD Certificate;
• Other documents that applicant may consider to be relevant to prove the scientific course.

Note: Candidates who incorrectly formalize their application or do not submit the documents proving the compliance with the requirements indicated in the call will be excluded. The jury has the right to require to any candidate, in case of doubt, to present documents proving their statements.

Non-discrimination and equal access policy

GIMM promotes a non-discrimination and equal access policy, wherefore no candidate can be privileged, benefited, impaired or deprived of any rights whatsoever, or be exempt of any duties based on their ancestry, age, sex, sexual preference, marital status, family and economic conditions, instruction, origin or social conditions, genetic heritage, reduced work capacity, disability, chronic illness, nationality, ethnic origin or race, origin territory, language, religion, political or ideological convictions and union membership.

International environment and experience

D